UPCOMING:

ASCO 2012 Annual Meeting

PREVIOUS:

Lunch Plenary session – Redefining Exit Options Given the Current Economic Climate
Moderator: Michael O’Donnel – Partner, Morrison & Foerster
- Mark Barrett – Senior Director, Business Development, Johnson & Johnson
- Stephen Dunn – President, Senior Managing Director of Research, LifeTech Capital
- Johathan MacQuitty – Partner, Abingworth Management
- Benjamin Perkins – Sr. Mng. Director, US Life Sciences M&A, Ernst & Young Capital Advisors
- Gaurav Aggarwal – Partner, Panorama Capital

Alternative Financing Options for Life Science Companies
Moderator: Luke Duster – Principal, Capital Royalty
- Sachin Kelkar – Managing Director, Investment Banking, LifeTech Capital
- Kristen Kosofsky – Managing Director, Horizon Technology Finance
- Ram May-Ron – Managing Partner, FreeMind Group
- Michael Nowak, PhD – Managing Director, Head of Healthcare, Yorkville Advisors

Infectious Disease: Fighting the #2 Global Killer
Moderator: Stephen Dunn – President, Senior Managing Director of Research, LifeTech Capital
- J. Joseph Kim – Chief Executive Officer, Inovio Pharmaceuticals (Amex:INO)
- Frank Oakes – Chief Executive Officer, Stellar Biotechnologies (TSXV:KLH)
- John Trizzino, Chief Executive Officer, Immunovaccine Inc. (TSXV:IMV)
- Raphael Gernot Klingmann – Chief Executive Officer, Omnia Molecular
- David Martin – Chief Executive Officer, AvidBiotics

ASCO 2011 Annual Meeting

Molecular Diagnostics Discussion

Infectious Diseases Discussion

Oncology Devices Discussion

LifeTech Capital Miami Medical Investors Conference

Oncology Drug Discussion